Type Public company Headquarters Mumbai Founded May 1956 | Industry Pharmaceuticals Number of employees 1,840 | |
 | ||
Traded as BSE: 500674
NSE: AVENTIS Key people Dr. Shailesh Ayyangar (MD) Products Prescription and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines (list...) Revenue ₹10,855.0 million (US$160 million) (2009–2010) Stock price SANOFI (NSE) ₹ 4,310.00 +48.70 (+1.14%)3 Mar, 3:30 PM IST - Disclaimer | ||
Aventis Pharma Limited, headquartered in Mumbai, is a part of Sanofi-Aventis group. Sanofi-Aventis and its wholly owned subsidiary Hoechst AG, are the major shareholders of Aventis Pharma Limited. Its manufacturing portfolio contains medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine. Its primary business is medicines in the dosage forms of liquid injectables, tablets, capsules, ointments, drops and syrup. In July 2003, company launched Lantus, the world's first and only once a day insulin.
History
Aventis Pharma Limited was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited and Hoechst Marion Roussel Limited.
As of August 2012, it is part of Sanofi.